318-632-7255
Where Proven Science Meets Heart Health
EECP therapy has been the subject of extensive clinical research for more than three decades, with dozens of peer-reviewed studies published in leading cardiology journals. Large multi-center trials and long-term follow-up studies have consistently shown that EECP can reduce the frequency of angina, improve exercise capacity, and enhance quality of life for patients with coronary artery disease and heart failure. Many of these studies demonstrate that the benefits of therapy are not just short-term but can last for years, offering sustained improvements in functional status and symptom relief—particularly valuable for individuals opting for non-surgical routes to manage their heart disease.
The therapy’s credibility is further supported by research conducted at world-renowned institutions, including the Mayo Clinic, Cleveland Clinic, and Johns Hopkins Medicine. These centers, along with others across the United States and internationally, have documented positive outcomes in patients who had exhausted conventional treatment options or were seeking alternatives to surgery. Collectively, this body of evidence has helped establish EECP as an evidence-based, non-invasive therapy recognized by the FDA and trusted by physicians worldwide.
EECP therapy plays a unique role in helping the heart build collateral arteries, often referred to as the body’s natural bypass system. When a person has blockages in their coronary arteries, blood flow to the heart muscle is reduced, leading to chest pain, shortness of breath, and fatigue. Unlike surgery, which creates a man-made bypass, EECP works with the body’s own physiology. During treatment, cuffs placed around the legs inflate and deflate in sync with the heartbeat. This action boosts blood flow back to the heart during diastole, the heart’s relaxation phase, which increases pressure inside the coronary arteries. Over time, this repeated increase in blood flow stimulates the release of nitric oxide and vascular growth factors, signaling the body to form new collateral arteries.
These collateral arteries branch around blocked or narrowed vessels, opening up alternative pathways for blood to reach areas of the heart muscle that were previously starved of oxygen. This process is known as angiogenesis—the growth of new blood vessels from existing ones. The result is improved circulation, better oxygen delivery to the heart, and a reduction in symptoms such as angina and fatigue. Patients who complete EECP therapy often experience greater exercise tolerance, improved energy, and a renewed ability to enjoy daily activities without debilitating chest pain. In essence, EECP gives the heart a second chance by building its own natural bypasses—safely, non-invasively, and effectively.
Counterpulsation: Your Heart’s Workout Without the Workout
How does Circulate Therapy work ?
